ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2623

A CT Evaluation Of Pulmonary and Cardiac Lesions In BEHÇET’S Syndrome Patients Without Pulmonary Symptoms

Emire Seyahi1, Deniz Cebi Olgun2, SerdaL Ugurlu1, Idil Hanci3, Reona Takahashi4 and Hasan Yazici1, 1Division of Rheumatology,Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 2Department of Radiology,, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 3Department of Neurology, Krankrenhaus Nordwest, Frankfurt am Main, Frankfurt, Germany, 4Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, Cardiovascular disease, Pulmonary Involvement, thrombosis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose:  In Behçet’s syndrome (BS) patients with symptomatic pulmonary artery involvement (PAI) varying and multiple pulmonary parenchymal and cardiac lesions can be seen in thorax CT examinations (1).  These lesions are pulmonary nodules of ≥ 1 cm (85 %), cavities (47 %), ground-glass opacities (45 %), mild pleural (45 %) and pericardial effusions (21 %), mediastinal lymphadenopathies (21 %) and intracardiac filling defects (28 %). Whether these pulmonary and cardiac abnormalities are exclusively observed in symptomatic BS with PAI or in vascular involvement without PAI have not been adequately studied. We now report the frequency of such lesions among BS patients with vascular disease but no PAI along with BS patients with no vascular disease at all.

Methods: Consecutive BS patients seen in the outpatient clinic between December 2011 and November 2012 were studied. Those with a disease duration of > 5 years were excluded. Contrasted thorax CT scans were obtained in BS patients with vascular disease along with BS patients with no vascular disease at all. Only patients with no prior history relevant with PAI or those with no pulmonary symptoms such as hemoptysis, cough, chest pain and dyspnea were studied. CT scans were analyzed formally using a checklist by a radiologist who was blinded to the clinical diagnoses of the patients.

Results: We studied 49 (43 M/ 6 F) BS patients with vascular involvement and 35 (32 M/3 F) BS patients with no vascular involvement. Lower extremity deep or superficial vein thrombosis was present in all 49 patients with vascular involvement. The mean age (32 ± 7 years vs 33 ± 8 year, respectively) and disease duration (4 ± 3 years vs 3 ± 2 years, respectively) among patients with and without vascular involvement were similar. None of the patients had pulmonary artery aneurysms or thrombosis. Similarly, cavities, pleural or pericardial effusions, and intracardiac filling defects were not observed in any of the scans. The most common parenchymal lesions were nodules of < 1 cm, which were present in 61 % and 37 % patients with and without vascular involvement, respectively, (P = 0.029). Nodules of ≥ 1 cm were only present in 4 patients with vascular disease (8 %) and none of those with no vascular disease. Ground-glass opacities were present in 2 and 3 patients with and without vascular involvement, respectively. The frequency of pulmonary and cardiac lesions in the current study was much less when compared to that found in PAI. 

Conclusion:  Pulmonary parenchymal and cardiac lesions were rarely observed in BS patients with no pulmonary artery involvement. Although small pulmonary nodules (<1 cm) seemed to be more frequent among patients with vascular disease compared to those without, their significance remains to be further studied.

References: 1) Seyahi E et al. Pulmonary artery involvement and associated lung disease in Behçet disease: a series of 47 patients. Medicine (Baltimore). 2012;91:35-48.


Disclosure:

E. Seyahi,
None;

D. Cebi Olgun,
None;

S. Ugurlu,
None;

I. Hanci,
None;

R. Takahashi,
None;

H. Yazici,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-ct-evaluation-of-pulmonary-and-cardiac-lesions-in-behcets-syndrome-patients-without-pulmonary-symptoms/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology